News | December 08, 2011

Accuray Receives Outstanding Innovative Improvement Award for its CyberKnife System

December 8, 2011 – Accuray, a radiation oncology, company, announced that the company received the Outstanding Innovative Improvement Award for its CyberKnife Robotic Radiosurgery System at the 3rd Annual Employer Healthcare Congress, which took place October 25 – 28, 2011 in Chicago.

The award was presented to Accuray in recognition of the fact that patients treated with the CyberKnife System are able to complete treatment in five days or less, compared with radiation therapy treatments, which typically require up to 40 treatment sessions. This significant reduction in the number of daily treatments helps patients get back to work faster, benefitting employees and employers alike. The CyberKnife System targets tumors anywhere in the body and delivers high doses of radiation with pinpoint accuracy. Unlike any other radiation delivery system, the CyberKnife System tracks and adjusts treatment delivery to compensate for tumor motion, including respiration.

"Treatment with the CyberKnife System is typically completed in five or fewer outpatient sessions, compared to the six weeks of daily treatments typical with conventional radiation. Fewer daily treatments allow the employee to get back to their normal schedule, including work, resulting in less stress for the employee and a more efficient workplace for the employer," said Jonathan Edelheit, president of the Employer Healthcare Congress. "Accuray has made a tremendous effort to ensure that employees are aware of the full range of options so they can make an informed treatment decision. We wanted to recognize Accuray's innovative technology, as well as its education efforts with this award."

The Employer Healthcare Congress is among the largest healthcare conferences in the United States. One of the major highlights of the conference is the Leadership Awards given for both excellence in Corporate Wellness and Voluntary Benefits. The Outstanding Innovative Improvement Award honors a company that not only has brought a healthy innovation to employees, but also a cutting-edge approach to changing the way we deal with chronic illness and critical care, all while helping employers reduce healthcare costs.

"Accuray is honored to receive this award from the Employer Healthcare Congress recognizing the advantages that the CyberKnife System offers not only to employees, but employers as well," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "This award reaffirms our commitment to developing personalized, leading-edge treatment solutions that help cancer patients live longer, better lives. This means not only treating their tumors, but also helping them return to their normal lives as soon as possible."

For more information: www.accuray.com

 

Related Content

New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018.

Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018. 

Feature | May 01, 2019
May 1, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine webs
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
Researchers Identify Ways to Predict and Avoid Radiotherapy Side Effects
News | Radiation Therapy | April 30, 2019
New research has shown a combination of biological markers and certain genetic changes can predict radiation...